Biomark Diagnostics Inc. (CSE: BUX)
Canada
· Delayed Price · Currency is CAD 0.260
0.00 (0.00%)
Sep 24, 2024, 9:30 AM EDT
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 38.31K CAD in the quarter ending June 30, 2024, a decrease of -3.61%. This brings the company's revenue in the last twelve months to 161.79K, up 2.83% year-over-year. In the fiscal year ending March 31, 2024, Biomark Diagnostics had annual revenue of 163.22K with 6.34% growth.
Revenue (ttm)
161.79K
Revenue Growth
+2.83%
P/S Ratio
140.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
20.39M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries Inc. | 1.52B |
| Trulieve Cannabis Corp. | 1.59B |
| Cresco Labs Inc. | 1.01B |
| Ayr Wellness Inc. | 635.84M |
| Planet 13 Holdings Inc. | 139.22M |
| Jushi Holdings Inc. | 360.23M |
| Grown Rogue International Inc. | 28.83M |
| iAnthus Capital Holdings, Inc. | 229.29M |